Studies have shown that AKR1B10 can induce a variety of cancers, such as liver cancer (25), non-small cell lung cancer (26), and pancreatic cancer (27), and represents a promising potential cancer target. Here, AKR1B10 is linked to non-small cell lung carcinoma.